Advertisement

Specific and Nonspecific Heart Defenses in Enteroviral Infections

  • C. J. Gauntt
  • A. L. Higdon
  • H. M. Arizpe
  • E. A. Maull
  • C. W. Lutton
  • M. A. Beck
  • N. M. Chapman
  • B. McManus
  • J. C. Mullican
  • S. M. Tracy
Conference paper

Abstract

Enterovirus infections of humans are common [31], with the majority being asymptomatic [6]. These viruses, particularly the coxsackieviruses group B (CVB) are associated with diseases of the heart [26, 27], with acute myocarditis occurring in up to 5% of infected individuals [26, 40]. Neonatal myocarditis is a severe disease and contributes to mortality in infants and young children [6, 26, 27]. Among the CVB, coxsackievirus B3 (CVB3) is most frequently associated with acute myocarditis [34]. Acute disease can progress to chronic myocarditis, and clinical laboratory data suggest that some cases of chronic disease develop into idiopathic dilated cardiomyopathy [26, 27, 33, 35].

Keywords

HeLa Cell Viral Myocarditis Acute Myocarditis Enteroviral Infection Chronic Myocarditis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Beck MA, Chapman NM, McManus BM, Mullican JC, Tracy S (1990) Secondary enterovirus infection in the murine model of myocarditis. Am J Pathol 136:669–681PubMedGoogle Scholar
  2. 2.
    Beck MA, Tracy SM (1989) Murine cell-mediated immune response recognizes an enterovirus group-specific antigen(s). J Virol 63:4148–4156PubMedGoogle Scholar
  3. 3.
    Beck MA, Tracy SM (1990) Evidence for a group-specific enteroviral antigen(s) recognized by human T cells. J Clin Microbiol 28:1822–1827PubMedGoogle Scholar
  4. 4.
    Beck MA, Tracy S, Coller BA, Chapman NM, Hufnagel G, Johnson JE, Lomonossoff (1992) Comoviruses and enteroviruses share a T cell epitope. Virology 186:238–246PubMedCrossRefGoogle Scholar
  5. 5.
    Beisel KW, Traystman MD (1988) Viral myocarditis: immunogenetic and autoimmune aspects. In: Schultheiss HP (ed) New concepts in viral heart disease. Springer, Berlin Heidelberg New York, pp 148–159CrossRefGoogle Scholar
  6. 6.
    Cherry JD (1987) Enteroviruses: polioviruses (poliomyelitis), coxsackieviruses, echoviruses, and enteroviruses. In: Feigin RD, Cherry JD (eds) Textbook of pediatric diseases. Saunders, Phladelphia, pp 1729–1790Google Scholar
  7. 7.
    Chow LH, Gauntt CJ, McManus BM (1991) Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice: a pathologic characterization of heart tissue damage. Lab Invest 64:55–64PubMedGoogle Scholar
  8. 8.
    Crowell RL, Landau BJ (1983) Receptors in the initiation of picornavirus infections. In: Fraenkel-Conrat H, Wagner RR (eds) Comprehensive virology, vol 18. pp 1–42Google Scholar
  9. 9.
    Frisk G, Nilsson E, Ehrnst A, Diderholm H (1989) Enterovirus IgM detection: specificity of μ-antibody-capture radioimmunoassays using virions and procapsids of coxsackie B virus. J Virol Methods 24:191–202PubMedCrossRefGoogle Scholar
  10. 10.
    Gauntt CJ (1988) The possible role of viral variants in pathogenesis. In: Friedman H, Bendinelli M (eds) Coxsackieviruses - a general update. Plenum, New York, pp 159–179Google Scholar
  11. 11.
    Gauntt CJ, Arizpe HM, Higdon AL, Rozek MM, Crawley R, Cunningham MW (1991) Anti-coxsackievirus B3 neutralizing antibodies with pathologic potential. Eur Heart J 12 [Suppl D]:124–129PubMedGoogle Scholar
  12. 12.
    Gauntt CJ, Godeny EK, Lutton CW (1988) Host factors regulating viral clearance. Pathol Immunopathol Res 7:251–265PubMedCrossRefGoogle Scholar
  13. 13.
    Gauntt CJ, Godeny EK, Lutton CW, Arizpe HM, Chapman NM, Tracy SM, Revtyak GE, Valente AJ, Rozek MM (1988) Mechanism(s) of coxsackievirus-induced acute myocarditis in the mouse. In: de la Maza LM, Peterson E (eds) Medical virology VIII. Erlbaum, Hillsdale, pp 161–182Google Scholar
  14. 14.
    Gauntt GJ, Higdon AL, Arizpe HM, Tamayo MR, Crawley R, Henkel RD, Pereira ME A, Tracy SM, Cunningham MW (1992) Epitopes shared between coxsackievirus B3 (CVB3) and normal heart tissue contribute to CVB3-induced murine myocarditis. In: Rose NR, Baughman KL, Herskowitz A, Newmann DA (eds) immune mediated heart disease. Springer, Berlin Heidelberg New York (in press)Google Scholar
  15. 15.
    Gauntt CJ, Lutton CW, Arizpe HM, Higdon AH, Tracy SM (1991) Autoimmune reactions in coxsackievirus B3-induced murine myocaditis. Life Sci Adv 10:23–31Google Scholar
  16. 16.
    Gauntt CJ, Lutton CW, Revtyak GE, Valente AJ, Fernandes AN, Arizpe HM, Rozek MM (1988) Induction of soluble mediators during coxsackievirus B3 replication in vitro and in vivo. In: Schultheiss HP (ed) New concepts in viral heart disease. Springer, Berlin Heidelbergy New York, pp 93–104CrossRefGoogle Scholar
  17. 17.
    Godeny EK, Arizpe HM, Gauntt CJ (1988) Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3-induced myocarditis. Viral Immunol 1:305–314CrossRefGoogle Scholar
  18. 18.
    Godeny EK, Gauntt CJ (1986) Involvement of natural killer cells in coxsackievirus B3- induced murine myocarditis. J Immunol 137:1695–1702PubMedGoogle Scholar
  19. 19.
    Godeny EK, Gauntt CJ (1987) In situ immune autoradiographic identification of cells in heart tissues of mice with coxsackievirus B3-induced myocarditis. Am J Pathol 129:267–276PubMedGoogle Scholar
  20. 20.
    Godeny EK, Sprague EA, Schwartz CJ, Gauntt CJ (1986) Coxsackievirus group B replication in cultured fetal baboon aortic smooth muscle cells. J Med Virol 20:135–149PubMedCrossRefGoogle Scholar
  21. 21.
    Grist NR (1988) Epidemiology and pathogenicity of coxsackieviruses. In: Schultheiss HP (ed) New concepts in viral heart disease. Springer, Berlin Heidelberg New York, pp 26–32CrossRefGoogle Scholar
  22. 22.
    Halstead SB (1988) Pathogenesis of dengue: challenges to molecular biology. Science 239:476–481PubMedCrossRefGoogle Scholar
  23. 23.
    Herskowitz A, Wolfgram LJ, Rose NR, Beisel KW (1987) Coxsackievirus B3 murine myocarditis-marked strain differences in histopathologic features of early and late phase myocarditis. J Am Coll Cardiol 9:1311–1319PubMedCrossRefGoogle Scholar
  24. 24.
    Huber SA, Weller A, Herzum M, Lodge PA, Estrin M, Simpson K, Guthrie M (1988) Immunopathogenic mechanisms in experimental picornaviros-induced autoimmunity. Pathol Immunopathol Res 7:279–291PubMedCrossRefGoogle Scholar
  25. 25.
    Katze MG, Crowell RL (1980) Immunological studies of the group B coxsackieviruses by the sandwich enzyme-linked immunosorbent assay (ELISA) and immunoprecipitation. J Gen Virol 50:357–367PubMedCrossRefGoogle Scholar
  26. 26.
    Leslie K, Blay R, Haisch C, Lodge A, Weller A, Huber S (1989) Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev 2:191–203PubMedGoogle Scholar
  27. 27.
    McManus BM, Gauntt CJ, Cassling RS (1987) Immunopathologic basis of myocardial injury. Cardiovasc Clin 18:163–184Google Scholar
  28. 28.
    Mitchell DM, McMichael AJ, Lamb RA (1985) The immunology of influenza. Br Med Bull 41:80–86PubMedGoogle Scholar
  29. 29.
    Murphy BR, Chanock RM (1991) Immunization against viruses. In: Fields BN, Knipe DM (eds) Fundamental virology, 2nd edn. Raven, New York, pp 371–404Google Scholar
  30. 30.
    Neu N, Rose NR, Beisel KW, Herskowitz A, Gurri-Glass G, Craig SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139:3630–3636PubMedGoogle Scholar
  31. 31.
    Pallansch MA (1988) Epidemiology of group B coxsackieviruses. In: Bendinelli M, Friedman H (eds) Coxsackieviruses - a general update. Plenum, New York, pp 399–417Google Scholar
  32. 32.
    Pattison JR (1983) Tests for coxsackie B virus-specific IgM. J Hyg 90:327–332CrossRefGoogle Scholar
  33. 33.
    Reyes MP, Lerner AM (1988) Myocarditis. Clinical and experimental correlates. In: Bendinelli M, Friedman H (eds) Coxsackieviruses - a general update. Plenum, New York, pp 253–270Google Scholar
  34. 34.
    Rose NR, Neu N, Neumann DA, Herskowitz A (1988) Myocarditis: a postinfectious autoimmune disease. In: Schultheiss HP (ed) New concepts in viral heart disease. Springer, Berlin Heidelberg New York, pp 139–147CrossRefGoogle Scholar
  35. 35.
    See DM, Tilles JG (1991) Viral myocarditis. Rev Infect Dis 13:951–956PubMedCrossRefGoogle Scholar
  36. 36.
    Su H, Spangrude GJ, Caldwell HD (1991) Expression of Fcy RIII on HeLa 229 cells: possible effect on in vitro neutralization of Chlamydia trachomatis. Infect Immun 59: 3811–3814PubMedGoogle Scholar
  37. 37.
    Tracy S, Chapman NM, Beck MA (1991) Molecular biology and pathogenesis coxsackie B viruses. Rev Med Virol 1:145–154CrossRefGoogle Scholar
  38. 38.
    van Houten N, Huber S (1989) Role of cytotoxic T cells in exptl. myocarditis. Springer Semin Immunopathol 11:61–68PubMedCrossRefGoogle Scholar
  39. 39.
    Wolfgram LJ, Beisel KW, Herskowitz A, Rose NR (1986) Variations in the susceptibility to coxsackievirus B3-induced myocarditis among different strains of mice. J Immunol 136:1846–1852PubMedGoogle Scholar
  40. 40.
    Wolfgram LJ, Rose NR (1989) Coxsackievirus infection as a trigger of cardiac autoimmunity. Immunol Res 8:61–80PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1993

Authors and Affiliations

  • C. J. Gauntt
    • 1
    • 2
    • 3
  • A. L. Higdon
    • 1
    • 2
    • 3
  • H. M. Arizpe
    • 1
    • 2
    • 3
  • E. A. Maull
    • 1
    • 2
    • 3
  • C. W. Lutton
    • 1
    • 2
    • 3
  • M. A. Beck
    • 1
    • 2
    • 3
  • N. M. Chapman
    • 1
    • 2
    • 3
  • B. McManus
    • 1
    • 2
    • 3
  • J. C. Mullican
    • 1
    • 2
    • 3
  • S. M. Tracy
    • 1
    • 2
    • 3
  1. 1.Department of MicrobiologyThe University of Texas Health Science Center at San AntonioSan AntonioUSA
  2. 2.Department of NeurologyUniversity of Utah Medical CenterSalt Lake CityUSA
  3. 3.Department of Pathology and MicrobiologyUniversity of Nebraska, Medical CenterOmahaUSA

Personalised recommendations